Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST).

Autor: Al-Lehebi RO; King Fahad Medical City, Riyadh, Saudi Arabia.; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., Al Ahmad M; College of Medicine, Kuwait University, Kuwait City, Kuwait., Maturu VN; Yashoda Super Speciality Hospital, Hyderabad, India., Mesa AG; Servicios de Salud Ips Suramericana SAS, Medellín, Antioquia, Colombia., Mahboub B; Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates., Garcia E; Unidad Médico Quirúrgica de ORL, Medical Faculty Universidad de los Andes, Fundación Santa Fe de Bogotá, Bogotá, Colombia., Fernandez P; Chilean National Institute, Santiago, Chile., Soares C; Real-World Evidence Matrix Team, Emerging Markets, Value Evidence & Outcomes, GSK, Rio de Janeiro, Brazil., Abreu G; Real-World Evidence Matrix Team, Emerging Markets, Value Evidence & Outcomes, GSK, Rio de Janeiro, Brazil., Dos Santos D; Real-World Evidence Matrix Team, Emerging Markets, Value Evidence & Outcomes, GSK, Rio de Janeiro, Brazil., Queiroz J; Real-World Evidence Matrix Team, Emerging Markets, Value Evidence & Outcomes, GSK, Rio de Janeiro, Brazil., Raimondi A; GSK, Buenos Aires, Argentina., Laucho-Contreras M; GSK, Bogotá, Colombia.; Fundación Neumológica de Colombia, Bogotá, Colombia., Noibi S; GSK, Jeddah, Saudi Arabia., Levy G; Emerging Markets, GSK, Panama City, Panama., Bavbek S; Department of Chest Diseases, Division of Immunology and Allergic Diseases, Ankara University School of Medicine, Ankara, Turkey. sevim.bavbek@medicine.ankara.edu.tr.

Publikováno v: Advances in therapy [Adv Ther] 2024 Nov; Vol. 41 (11), pp. 4008-4031. Date of Electronic Publication: 2024 Aug 31.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?

Autor: Polverino F; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Room 855B, Harvard Institutes of Medicine Building, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.; Lovelace Respiratory Research Institute, Albuquerque, NM USA.; University of Parma, Parma, Italy., Laucho-Contreras M; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Room 855B, Harvard Institutes of Medicine Building, 77 Avenue Louis Pasteur, Boston, MA 02115 USA., Rojas Quintero J; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Room 855B, Harvard Institutes of Medicine Building, 77 Avenue Louis Pasteur, Boston, MA 02115 USA., Divo M; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Room 855B, Harvard Institutes of Medicine Building, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.; Lovelace Respiratory Research Institute, Albuquerque, NM USA., Pinto-Plata V; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Room 855B, Harvard Institutes of Medicine Building, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.; Lovelace Respiratory Research Institute, Albuquerque, NM USA., Sholl L; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA., de-Torres JP; Clinica Universidad de Navarra, Pamplona, Spain., Celli BR; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Room 855B, Harvard Institutes of Medicine Building, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.; Lovelace Respiratory Research Institute, Albuquerque, NM USA., Owen CA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Room 855B, Harvard Institutes of Medicine Building, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.; Lovelace Respiratory Research Institute, Albuquerque, NM USA.

Publikováno v: Multidisciplinary respiratory medicine [Multidiscip Respir Med] 2016 Apr 04; Vol. 11, pp. 17. Date of Electronic Publication: 2016 Apr 04 (Print Publication: 2016).

B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.

Autor: Polverino F; 1 Division of Pulmonary and Critical Care Medicine and.; 2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico.; 3 University of Parma, Parma, Italy., Cosio BG; 4 Research Unit, FISIB, IdISPa, and.; 5 Department of Respiratory Medicine, Hospital Son Espases, Ciber de Enfermedades Respiratorias (CIBERES), Mallorca, Spain., Pons J; 4 Research Unit, FISIB, IdISPa, and.; 6 Immunology Department, Hospital Son Espases, Mallorca, Spain., Laucho-Contreras M; 1 Division of Pulmonary and Critical Care Medicine and., Tejera P; 7 Harvard School of Public Health, Boston, Massachusetts; and., Iglesias A; 4 Research Unit, FISIB, IdISPa, and., Rios A; 4 Research Unit, FISIB, IdISPa, and., Jahn A; 4 Research Unit, FISIB, IdISPa, and., Sauleda J; 4 Research Unit, FISIB, IdISPa, and.; 5 Department of Respiratory Medicine, Hospital Son Espases, Ciber de Enfermedades Respiratorias (CIBERES), Mallorca, Spain., Divo M; 1 Division of Pulmonary and Critical Care Medicine and.; 2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico., Pinto-Plata V; 1 Division of Pulmonary and Critical Care Medicine and.; 2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico., Sholl L; 8 Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Rosas IO; 1 Division of Pulmonary and Critical Care Medicine and.; 2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico., Agustí A; 5 Department of Respiratory Medicine, Hospital Son Espases, Ciber de Enfermedades Respiratorias (CIBERES), Mallorca, Spain.; 9 Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona, and CIBERES, FISIB, Mallorca, Spain., Celli BR; 1 Division of Pulmonary and Critical Care Medicine and.; 2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico., Owen CA; 1 Division of Pulmonary and Critical Care Medicine and.; 2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico.

Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2015 Sep 15; Vol. 192 (6), pp. 695-705.

Role of microRNA-16-5p, microRNA-194, IP-10 and APRIL in inducing inflammation in SARS-CoV-2 infected patients with severe symptoms.

Autor: Sarrafi, Omidreza¹, Kariminik, Ashraf¹ a.kariminik@iauk.ac.ir, Arababadi, Mohammad Kazemi²

Publikováno v: Indian Journal of Experimental Biology. Nov2023, Vol. 61 Issue 11, p888-892. 5p.